SEC Form 4 · accession 0001019687-15-004405
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McLaughlin
Director
Period of report
Nov 30, 2015
Accepted (ET)
Dec 2, 2015 · 8:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Rights to Buy)F1 | $1.24 | Nov 30, 2015 | A | 7,488 | A | Nov 30, 2015 | Nov 30, 2025 | Common Stock | 7,488 | 146,144 | D |
Explanation of responses
- F1The options were granted by the Issuer pursuant to the Non-Employee Director Compensation Plan.